Showing results (111-120 of 161) with videos related to

Sort By:
Pageof 17
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 20, 2011
Inverse association between yoghurt intake and upper aerodigestive tract cancer risk in a Japanese populationDaisuke Kawakita, Fumihito Sato, Satoyo Hosono, et al.
Frontiers in Oncology|January 23, 2025
Indications for chemoradiotherapy in older patients with locally advanced head and neck cancer in Japan: a questionnaire survey in the JCOG head and neck cancer study groupKoichi Yasuda, Naomi Kiyota, Kazuto Matsuura, et al.
Histopathology|June 9, 2017
MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinomaKana Fujii, Takayuki Murase, Shintaro Beppu, et al.
Frontiers in Oncology|April 25, 2025
Corrigendum: Indications for chemoradiotherapy in older patients with locally advanced head and neck cancer in Japan: a questionnaire survey in the JCOG head and neck cancer study groupKoichi Yasuda, Naomi Kiyota, Kazuto Matsuura, et al.
Auris, Nasus, Larynx|December 13, 2021
Distribution pattern and pathologic analysis of metastatic sentinel and non-sentinel lymph nodes in lymphatic basin dissection for clinical T2/T3 oral cancer with clinical N0 statusHitoshi Hirakawa, Takashi Matsuzuka, Hirokazu Uemura, et al.
Japanese Journal of Clinical Oncology|June 24, 2026
A multicenter randomized phase III trial of weekly cisplatin chemoradiotherapy versus radiotherapy in elderly patients with head and neck squamous cell carcinoma unfit for high-dose cisplatin: JCOG2405 (ELDER-WEEKLY)Kota Kawabata, Koichi Yasuda, Satoaki Nakamura, et al.
Histopathology|April 4, 2017
Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinomaShintaro Beppu, Yohei Ito, Kana Fujii, et al.
International Journal of Clinical Oncology|March 30, 2024
Survival impact of sequential chemotherapy following pembrolizumab for recurrent or metastatic head and neck squamous cell carcinomaSho Iwaki, Shigenori Kadowaki, Kazunori Honda, et al.
International Journal of Clinical Oncology|January 13, 2025
Paclitaxel plus cetuximab versus nivolumab for patients with platinum-refractory recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysisHiroyuki Kodama, Shigenori Kadowaki, Yasunobu Ishizuka, et al.
Cancer Genetics|March 11, 2025
Biological landscape of human papilloma virus-related head and neck cancer according to virus genotypeKatsuhiro Masago, Hiromasa Ishihara, Hiroaki Kuroda, et al.
Pageof 17